Do you want to read an article? Please log in or register.
The vasopressin biomarker copeptin is linked to systemic inflammation and refines prognostication in decompensated cirrhosis
Hepatology
Indications
Related content
Hepatology
Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis
Gut
Trebicka J, Aguilar F, Queiroz Farias A, Lozano JJ, Sánchez-Garrido C, Usón-Raposo E, de la Peña-Ramirez C, Sidorova J, Curto-Vilalta A, Sierra-Casas P, Momoyo Zitelli P, Papp M, Pereira G, Caraceni P, Goncalves LL, Alessandria C, Torre A, Laleman W, Gadano A, Piano S, Mattos AZ, Gu W, Brol MJ, Schierwagen R, Uschner FE, Fischer J, Mendes LSC, Vargas V, Alvares-da-Silva MR, Mookerjee R, Bittencourt PL, Benitez C, Albillos A, Couto C, Mendizabal M, Bañares R, Toledo CL, Mazo DF, Janicko M, Castillo-Barradas M, Padilla Machaca PM, Gatti P, Miranda AZ, Malé-Velázquez R, Zipprich A, Castro-Lyra A, Gustot T, Bernal W, Gerbes AL, Jalan R, Fernández J, Angeli P, Carrilho FJ, Claria J, Moreau R, Arroyo V, PREDICT study and ACLARA study
doi: 10.1136/gutjnl-2024-333876
Hepatology
Prognostic Communication, Symptom Burden, Psychological Distress, and Quality of Life Among Patients with Decompensated Cirrhosis
Clin Gastroenterol Hepatol
Donlan J, Kaplan A, Noll A, Pintro K, Horick N, Zeng C, Edelen M, Soetan Z, Comrie C, Indriolo T, Li L, Zhu E, Armstrong ME, Thompson LL, Zhou J, Diop MS, Mason N, Engel KG, Rowland M, Kenimer S, O'Brien K, Lai JC, Jackson V, Chung RT, El-Jawahri A, Ufere NN
doi: 10.1016/j.cgh.2024.10.017
Gastrointestinal Cancer
Refinement of histologic subtypes and identification of biomarkers linked to unfavorable prognosis in cholangiocarcinoma: The ENSCCA registries' framework for digital twin advancement
Hepatology
Carpino G, Overi D, Macias RI, Cardinale V, Izquierdo-Sanchez L, Acedo P, Rengo M, Doukas M, Kendall TJ, Calderaro J, Heij LR, Reichel K, Leone S, Onori P, Franceschini B, Soldani C, Di Tommaso L, Rodrigues PM, Augustin J, Brustia R, Torzilli G, Martin-Izquierdo M, Hernández-Bayo JM, Bueno-Sacristan D, Lanza E, Garcia-Sampedro A, Quaglia A, Ardito F, De Rose AM, Giuliante F, Damato E, Panebianco V, Groot Koerkamp B, Pereira SP, Grazi GL, Alvaro D, Lleo A, Banales JM, Gaudio E
doi: 10.1097/HEP.0000000000001425
Hepatology
Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
J Hepatol
Fortea JI, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernández-Gea V, Aracil C, Llop E, Puente A, Roig C, Reiberger T, García-Pagan JC, Calleja JL, Ferrero-Gregori A, Mandorfer M, Villanueva C, Crespo J
doi: 10.1016/j.jhep.2024.12.017
Hepatology
Impaired whole blood thrombin generation is associated with procedure-related bleeding in acutely decompensated cirrhosis
J Hepatol
Zanetto A, Campello E, Bulato C, Willems R, Konings J, Roest M, Gavasso S, Nuozzi G, Toffanin S, Burra P, Russo FP, Senzolo M, de Laat B, Simioni P
doi: 10.1016/j.jhep.2024.12.008
Gastrointestinal Cancer
Circulating Inflammation Biomarkers and the Risk of Esophageal Adenocarcinoma: A Nested Case-control Study in the Department of Defense Serum Repository
Cancer Epidemiol Biomarkers Prev
Omofuma OO, Rusiecki JA, Petrick JL, Falk RT, Wheeler W, Pfeiffer RM, Camargo MC, Cook MB
doi: 10.1158/1055-9965.EPI-24-1544
Hepatology
β-BLOCKERS LOWER FIRST DECOMPENSATION IN PATIENTS WITH CIRRHOSIS AND ENDURING PORTAL HYPERTENSION AFTER ETIOLOGICAL TREATMENT
Clin Gastroenterol Hepatol
Turco L, Taru MG, Vitale G, Stefanescu H, Mirici Cappa F, Berardi S, Baldan A, Di Donato R, Pianta P, Vero V, Vizioli L, Procopciuc LM, Procopet B, Morelli MC, Piscaglia F
doi: 10.1016/j.cgh.2024.08.012
Hepatology
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
Gastroenterology
Marsh TL, Parikh ND, Roberts LR, Schwartz ME, Nguyen MH, Befeler A, Page-Lester S, Tayob N, Srivastava S, Rinaudo JA, Singal AG, Reddy KR, Marrero JA
doi: 10.1053/j.gastro.2024.09.008
Hepatology
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study
Lancet Gastroenterol Hepatol
Patidar KR, Ma AT, Juanola A, Barone A, Incicco S, Kulkarni AV, Hernández JLP, Wentworth B, Asrani SK, Alessandria C, Abdelkader NA, Wong YJ, Xie Q, Pyrsopoulos NT, Kim SE, Fouad Y, Torre A, Cerda E, Ferrer JD, Maiwall R, Simonetto DA, Papp M, Orman ES, Perricone G, Solé C, Lange CM, Farias AQ, Pereira G, Gadano A, Caraceni P, Thevenot T, Verma N, Kim JH, Vorobioff JD, Cordova-Gallardo J, Ivashkin V, Roblero JP, Maan R, Toledo C, Gioia S, Fassio E, Marino M, Nabilou P, Vargas V, Merli M, Goncalves LL, Rabinowich L, Krag A, Balcar L, Montes P, Mattos AZ, Bruns T, Mohammed A, Laleman W, Carrera E, Cabrera MC, Girala M, Samant H, Raevens S, Madaleno J, Kim RW, Arab JP, Presa J, Ferreira CN, Galante A, Allegretti AS, Takkenberg B, Marciano S, Sarin SK, Durand F, Ginès P, Angeli P, Solà E, Piano S, International Club of Ascites GLOBAL AKI team
doi: 10.1016/S2468-1253(25)00006-8